Clinical Trial Update: D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 study testing D-Cycloserine to enhance cognitive-behavioral therapy for acrophobia. The trial was sponsored by Sout…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acrophobia

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Southern Methodist University | Conditions: Phobic Disorders | Phase 3 | Status: COMPLETED | Results posted: 2013-02-21